news & events
ysios portfolio archive
23.12.15
TiGenix files Registration Statement for proposed initial public offering in the United States
21.12.15
Sanifit announces the creation of a Steering Committee for its Phase 2b ESRD Clinical Program with SNF472
25.11.15
Sanifit and Mitelos make available to Doctors and patients a new alternative in osteoporosis
19.11.15
TiGenix completes enrolment of its Phase I/II study in acute myocardial infarction
19.11.15
CVRx® Announces Expedited Access Pathway Designation by FDA for Barostim Therapy® for the Treatment of Heart Failure in Order to Accelerate Access for US Patients
14.10.15
Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M)
30.09.15
AM-Pharma publishes further preclinical data on recAP to treat Acute Kidney Injury
29.09.15
AM-Pharma and Pfizer Inc. shortlisted for “Best Partnership Alliance” in 2015 Scrip Awards
16.09.15
IRB Barcelona identifies the gene responsible for metastasis of breast cancer to the bone
15.09.15
TiGenix Business and Financial Update for the First Half of 2015